varegacestat
·Code: AL102
varegacestat: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Immunome Inc. (IMNM) | Phase 1 |
Clinical Trials (1)
A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Varegacestat in Participants With or Without Hepatic Impairment
Frequently asked questions
Who is developing varegacestat?
varegacestat is being developed by Immunome Inc..
How many clinical trials involve varegacestat?
BioSniper tracks 1 clinical trial involving varegacestat.
Get deeper analysis on varegacestat
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis